References
- Wolf DG, Falk R, Hacham M et al. Multidrug-Resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J Clin Microbiol 2001; 39: 4420–4425.
- Paphitou NI, Ostrosky-Zeichner L, Paetznick VL, Rodriguez JR, Chen E, Rex JH. In vitro antifungal susceptibili-ties of Trichosporon species. Antimicrob Agents Chemother 2002; 46: 1144–1146.
- Cawley MJ, Braxton GR, Haith Jr LR, Reilly KJ, Guilday RE, Patton ML. Trichosporon beigelii infection: experience in a regional burn center. Burns 2000; 26: 483–486.
- Watson KC, Kallichurum S. Brain abscess due to Trichosporon cuteneum. J Med Microbiol 1970; 3: 191.
- Gueho E, Improvisi L, de Hoog GS, Dupont B. Trichosporon on humans: a practical account. Mycoses 1994; 37: 3–10.
- Sugita T, Nishikawa A, Ikeda R, Shinoda T. Identification of medically relevant Trichosporon species based on sequences of internal transcribed spacer regions and construction of a database for Trichosporon identification. J Clin Microbiol 1999; 37: 1985–1993.
- National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-Second Edition. NCCLS document M27-A2. Wayne, PA: National Committee for Clinical Laboratory Standards, Wayne, PA, 2002.
- Arikan S, Hascelik G. Comparision of NCCLS microdi-lution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolates. Diag Microbiol Infect Dis 2002; 43: 107–111.
- Uzun O, Arikan S, Kocagöz S, Sancak B, Unal S. Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading. Diag Microbiol Infect Dis 2000; 38: 101–107.